Your browser doesn't support javascript.
loading
High-dose and low-dose varenicline for smoking cessation in adolescents: a randomised, placebo-controlled trial.
Gray, Kevin M; Rubinstein, Mark L; Prochaska, Judith J; DuBrava, Sarah J; Holstein, Ann R; Samuels, Larry; McRae, Thomas D.
Affiliation
  • Gray KM; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA. Electronic address: graykm@musc.edu.
  • Rubinstein ML; Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
  • Prochaska JJ; Department of Medicine, Stanford University, Stanford, CA, USA.
  • DuBrava SJ; Pfizer, New York, NY, USA.
  • Holstein AR; Pfizer, New York, NY, USA.
  • Samuels L; Pfizer, New York, NY, USA.
  • McRae TD; Pfizer, New York, NY, USA.
Lancet Child Adolesc Health ; 4(11): 837-845, 2020 11.
Article in En | MEDLINE | ID: mdl-32979939
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Smoking Cessation / Dose-Response Relationship, Drug / Varenicline Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Lancet Child Adolesc Health Year: 2020 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Smoking Cessation / Dose-Response Relationship, Drug / Varenicline Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Lancet Child Adolesc Health Year: 2020 Document type: Article Country of publication: United kingdom